Xiao-Xia Niu

472 total citations
15 papers, 290 citations indexed

About

Xiao-Xia Niu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Xiao-Xia Niu has authored 15 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 2 papers in Molecular Biology. Recurrent topics in Xiao-Xia Niu's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). Xiao-Xia Niu is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). Xiao-Xia Niu collaborates with scholars based in China, United States and Sierra Leone. Xiao-Xia Niu's co-authors include Dong Ji, Guofeng Chen, Fang Chu, Li Jin, Yingjie Ji, Xuezhang Duan, Hongmei Tang, Wengang Li, Zhiqiang Sun and Huijuan Duan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiao-Xia Niu

13 papers receiving 282 citations

Peers

Countries citing papers authored by Xiao-Xia Niu

Since Specialization

Citations

This map shows the geographic impact of Xiao-Xia Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Xia Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Xia Niu more than expected).

Fields of papers citing papers by Xiao-Xia Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Xia Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Xia Niu. The network helps show where Xiao-Xia Niu may publish in the future.

Co-authorship network of co-authors of Xiao-Xia Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Xia Niu. A scholar is included among the top collaborators of Xiao-Xia Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Xia Niu. Xiao-Xia Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Leveraging the gut microbiome to understand the risk factor of cognitive impairment in patients with liver cirrhosis 2025 ·European Journal of Gastroenterology & Hepatology ·Shuyao Li, Xiao-Xia Niu, Jialiang Liu, Min Su, Qianqian Li, (unknown), Jianjun Wang, Hongyan Chen, (unknown)	0
2	Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitis 2024 ·PubMed ·Qianqian Li, Yüting Xiong, (unknown), Kexin Wang, (unknown), Yiming Fu, Xiao-Xia Niu, Chunyan Wang, Jianjun Wang, Dong Ji, (unknown)	1
3	Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury 2023 ·Frontiers in Pharmacology ·Yüting Xiong, Jianfei Wang, Xiao-Xia Niu, Yiming Fu, Kexin Wang, Chunyan Wang, Qianqian Li, Jianjun Wang, Jun Zhao, Dong Ji	4
4	Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study 2021 ·SHILAP Revista de lepidopterología ·Dong Ji, Guofeng Chen, Xiao-Xia Niu, Mingjie Zhang, Cheng Wang, Qing Shao, Vanessa Wu, Yu Wang, Gregory Cheng, Selwyn J. Hurwitz, Raymond F. Schinazi, George Lau	23
5	Estimated Annual Economic Burden of Dry Eye Disease Based on a Multi-Center Analysis in China: A Retrospective Study 2021 ·Frontiers in Medicine ·Wanju Yang, (unknown), (unknown), Xiao-Xia Niu, (unknown), (unknown), (unknown), Ying Zhang, Haoyu Wang, (unknown), (unknown), Ke Lan, (unknown), Liping Li, Shaowei Li, Qingyan Zeng	25
6	The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study 2021 ·Frontiers in Pharmacology ·Zhongbin Li, Dandan Chen, (unknown), (unknown), Guangde Zhou, Yiming Fu, (unknown), Xiao-Xia Niu, Fang Chu, (unknown), Zhengsheng Zou, Guofeng Chen, Dong Ji	8
7	Preclinical evaluation of TQB3602, a small molecule proteasome inhibitor clinical candidate. 2020 ·Journal of Clinical Oncology ·(unknown), Ling Yang, Xin Tian, Lihua He, Jian Xiong, Xiao-Xia Niu, Yuanfeng Xia, Li J, Shuhui Chen, Kevin Chen	1
8	Increase in Incidence of Hepatocellular Carcinoma in Chronic Hepatitis C Chinese After Sustained Virologic Response with Direct Acting Antiviral Agents as Compared to Pegylated Interferon Plus Ribavirin Therapy: A Prospective Open-Label Study 2019 ·SSRN Electronic Journal ·Dong Ji, Guofeng Chen, (unknown), Cheng Wang, Qing Shao, Vanessa Wu, Yu Wang, Xiao-Xia Niu, Gregory Cheng, Selwyn J. Hurwitz, Raymond F. Schinazi, George Lau	0
9	Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study 2017 ·Oncotarget ·Dong Ji, Yingjie Ji, Xuezhang Duan, Wengang Li, Zhiqiang Sun, Xueai Song, (unknown), Hongmei Tang, Fang Chu, Xiao-Xia Niu, Guofeng Chen, Li Jin, Huijuan Duan	183
10	Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients 2016 ·Hepatology International ·Dong Ji, Guofeng Chen, Cheng Wang, Yudong Wang, Qing Shao, Bing Li, Jun Zhao, Shaoli You, Jinhua Hu, Jialiang Liu, Xiao-Xia Niu, Jing Chen, Lei Lu, Vanessa Wu, George Lau	14
11	The Frequency and Determinants of Liver Stiffness Measurement Failure: A Retrospective Study of “Real-Life” 38,464 Examinations 2014 ·PLoS ONE ·Dong Ji, Qing Shao, Ping Han, Fan Li, Bing Li, Hong Zang, Xiao-Xia Niu, Zhongbin Li, Shaojie Xin, Guofeng Chen	14
12	Abstract 614: Proxalutamide (GT0918), a potent androgen receptor pathway inhibitor 2014 ·Cancer Research ·Youzhi Tong, Chunyun Chen, Juan Wu, (unknown), Huihui Zhang, Xiaojun Wu, (unknown), Wei Gao, (unknown), Xiao-Xia Niu, (unknown), Chuangxing Guo	13
13	Abstract 2460: Discovery of potent androgen receptor antagonists for treating CRPC and AR+ breast cancer. 2013 ·Cancer Research ·Youzhi Tong, Chunyun Chen, Juan Wu, Huihui Zhang, Xiaojun Wu, (unknown), Wei Gao, Xiao-Xia Niu, Linglan Ma, Chuangxing Guo	1
14	Analysis of the efficiency of FibroScan combined with serologic markers for diagnosing liver fibrosis 2011 ·Jiefangjun yixue zazhi ·Dong Ji, Qing Shao, Ping Han, Jian Zhang, Xiao-Xia Niu, Bing Li, Fan Li, Guofeng Chen	2
15	A compositive information collection platform system based on Web service 2006 ·Wuhan University Journal of Natural Sciences ·Zhenpeng Liu, Xiao-Xia Niu, Jianmin Xu, Lei Shi, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact